COVID + Flu Vaccine Study

Given that annual vaccinations against both influenza (flu) and SARS-CoV-2 (COVID-19) may be conducted in the future at a similar time of year, a combined vaccine targeting both viruses is likely to generate overall higher vaccination rates by allowing for more convenient scheduling. This is a partially placebo based study – participants may receive both vaccines or just one (but no participants will receive no vaccine).